Head and neck manifestation of Langerhans’ cell histiocytosis

Česká verzia

Authors: P. Smilek ¹; M. Pažourková ²
Authors place of work: Klinika otorinolaryngologie a chirurgie hlavy a krku Lékařské fakulty MU a FN u sv. Anny Brno, přednosta prof. MUDr. Rom Kostřica, CSc. ¹; Klinika zobrazovacích metod Lékařské fakulty MU a FN u sv. Anny Brno, přednosta doc. MUDr. Petr Krupa, CSc. ²
Published in the journal: Vnitř Lék 2010; 56(Supplementum 2): 76-84
Category: Langerhans cell histiocytosis and some other Hematology rare diseases

Summary

Head and neck region used to be involved in almost 90% of patients with Langerhans cell histiocytosis (LCH). Symptoms in head and neck region could be the first symptoms in multisystem disease. Physician should have a suspicion on LCH in patient with long lasting discharge from the ear not reacting on current antibiotic treatment, enlargement of neck lymph nodes and tumors in the orbit. Multisystem disease should be in patient with osteolytic lesions of the scull which are combined with endocrinology and neurology symptoms (diabetes insipidus etc). The base of treatment in multisystem disease is in systemic chemotherapy and radiotherapy; surgery has only palliative character, for instance mastoidectomy in advanced destruction of mastoid process of the temporal bone brings relief of pain. In localized (single site) lesions of LCH there is recommended surgery and topical application of steroids. Author describes three cases of patients with multisystem disease of LCH. One patient has been followed up for 33 years, she was treated with vinblastin (more than 126 time 10 mg i.v.), prednison, radiotherapy (focal dose was more than 100 Gy on the right temporal bone) and mastoidectomy with two revisions. Today there is diabetes insipidus, peripheral palsy of facial nerve, skin manifestation, advanced destruction of the temporal and occipital bone, atlantooccipital junction and probably intracerebral manifestation in right temporal lobe. Patient is now treated with cladribine and dexamethason. The second patient has been treated for 4 years with the temporal bone involvement and pulmonary disease with mastoidectomy, leustatin and radiotherapy. He is now in full remission. The third patient has been treated for 3 years with pulmonary involvement of LCH and chronic inflammation of external auditory meatus good reaction on antibiotic and antimycotic treatment (the diagnosis has not been established yet from the ear). Therapy with cladribine is now running.

Key words:
Langerhans cell histiocytosis and head and neck manifestation – mastoidectomy – surgery – chemotherapy and radiotherapy

Zdroje

1. Adam Z, Balšíková K, Krejčí M et al. Centrální diabetes insipidus u dospělých osob – první příznak histiocytózy z Langerhansových buněk a Erdheimovy-Chesterovy choroby. Popis tří případů a přehled literatury. Vnitř Lék 2010; 56: 138–148.

2. Akisada T, Harada T, Yoshihiro T et al. A case of bilateral eosinophilic granuloma in the temporal bone. Auris Nasus Larynx 1999; 26: 343–348.

3. Allen CE, McClain KL. Langerhans cell histiocytosis: a review of past, current and future therapies. Drugs Today 2007; 43: 627–643.

4. Aricò M, Girschikofsky M, Généreau T et al. Langerhans cell histiocytosis in adults, report from the International Registry of the Histiocyte Society. Eur J Cancer 2003; 39: 2341–2348.

5. Bottomley WK, Gabriel SA, Corio RL et al. Histiocytosis X: Report of an oral soft tissue lesion without bony involvement. Oral Surg Oral Med Oral Pathol 1987; 63: 228–231.

6. Perez CA, Brady LW. Principles and practice or radiation oncology. 2nd ed. Philadelphia: JB Lippincott 1992.

7. Ceci C, de Terlizzi M, Colella R et al. Langerhans cell histiocytosis in childhood: results from the Italian Cooperative AIEOP-CNR-H.X ’83 study. Med Pediatr Oncol 1993; 21: 259–264.

8. Davis SE, Rice DH. Langerhans’ cell histiocytosis: current trends and the role of the head and neck surgeon. Ear Nose Throat J 2004; 83: 340–350.

9. Devaney KO, Putzi MJ, Ferlito A et al. Head and neck Langerhans cell histiocytosis. Ann Otol Rhinol Laryngol 1997; 106: 526–532.

10. Fradis M, Podoshin J, Ben-David J et al. Eosinophilic granuloma of the temporal bone. J Laryngol Otol 1985; 99: 475–479.

11. Gianotti F, Caputo R. Histiocytic syndromes: a review. J Am Acad Dermatol 1985; 13: 383–404.

12. Greenberger JS, Rocker AC, Vawter G et al. Results of treatment of 127 patients with systemic histiocytosis. Medicine 1981; 60: 311–338.

13. Hudson WR, Kenan PD. Otologic manifestations of histiocytosis X. Laryngoscope 1969; 79: 678–693.

14. Irving RM, Broadbent V, Jones NS. Langerhans’ cell histiocytosis in childhood: management of head and neck manifestations. Laryngoscope 1994; 104: 67–70.

15. Ishii E, Matsuzaki A, Okamura J et al. Treatment of Langerhans cell histiocytosis in children with etoposide. Am J Clin Oncol 1992; 15: 515–517.

16. Ben-Ezra JM, Koo CH. Langerhans’ cell histiocytosis and malignancies of the M-PIRE system. Am J Clin Pathol 1993; 99: 464–471.

17. García de Marcos JA, Dean Ferrer A, Alamillos Grandos F et al. Langerhans cell histiocytosis in the maxillofacial area in adults. Report of three cases. Med Oral Pathl Oral Cir Bucal 2007; 12: E145–E150.

18. Mottl H, Mráček J, Kabelka Z et al. Histiocytóza z Langerhansových buněk u dětí. Čs Pediat 1992; 47: 530–533.

19. Najbrt V. Příspěvek k léčbě Histiocytózy X u dětí. Česk Dermatol 1978; 53: 24–27.

20. Nicollas R, Rome A, Belaïch H et al. Head and neck manifestation and prognosis of Langerhans’ cell histiocytosis in children. Int J Pediatr Otorhinolaryngol 2010; 74: 669–673.

21. O’Hare TJ. Granulomaouts and Lymphoproliferative Diseases of the Head and Neck. In: Thawley SE, Panje WR, Batsakis JG et al (eds). Comprehensive management of head and neck tumors. Philadelphia: W.B. Saunders company 1999: 1931–1981.

22. Ornvold K, Nielsen MH, Caluse N. Disseminated histiocytosis X. Acta Path Microbiol Immunol Scand 1985; 93: 311–316.

23. Satter EK, High WA. Langerhans cell histiocytosis: a review of the current recommendations of the Histiocyte Society. Pediatr Dermatol 2008; 25: 291–295.

24. Sawamura M, Yamaguchi S, Marayama Ket al. Cyclosporine therapy for Langerhans cell histiocytosis. Br J Haematol 1993; 83: 178–179.

25. Scolozzi P, Lombardi T, Monnier P et al. Multisystem Langerhans’ cell histiocytosis (Hand-Schüller-Christian disease) in an adult: a case report and review of the literature. Eur Arch Otorhinolaryngol 2004; 261: 326–330.

26. Smith RJ, Evans JN. Head and neck manifestations of histiocytosis X. Laryngoscope 1984; 94: 395–399.

27. Straka JA, Caparosa RJ. Eosinophilic granuloma of the temporal bone. Laryngoscope 1972; 82: 41–44.

28. Tantiwongkosi B, Goske MJ, Steele M. Congenital solid neck mass: a unique presentation of Langerhans cell histiocytosis. Pediatr Radiol 2008; 38: 575–578.

29. Tazi A, Bonay M, Grandsaigne M et al. Surface phenotype of Langerhans cells and lymphocytes in granulomatous lesions from patients with pulmonary histiocytosis X. Am Rev Respir Dis 1993; 147: 1531–1536.

30. Toohill RJ, Kidder TM, Eby LG. Eosinophilic granuloma of the temporal bone. Laryngoscope 1973; 83: 877–889.

31. Vincent T, De Vita H Jr. Cancer, principles and practice of Oncology. 3rd ed. Philadelphia: J.B. Lippincott company 1989.